Aon Aktie 51778893 / IE00BLP1HW54
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
08.10.2025 07:30:11
|
Aon Survey Projects Moderate Salary Growth of 5.3 percent for Southeast Asia in 2026
|
SINGAPORE - Media OutReach Newswire - 8 October 2025 - Aon plc (NYSE: AON), a leading global professional services firm, has announced the findings from its 2025 Salary Increase and Turnover Study for southeast Asia (SEA). The study, conducted from July to September 2025, analysed the salary adjustments and employee turnover rates of more than 700 businesses across Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam. The survey found that overall, the budgeted salary increases for SEA are projected at 5.3 percent for 2026.
When salaries are analysed across industries by country, the life sciences and medical devices industry is expected to have the highest increase in Singapore (4.6 percent), while technology leads in Vietnam (7.1 percent) and Indonesia (5.9 percent). The consulting, business and community services industry leads in Malaysia at 4.8 percent. Rahul Chawla, partner and head of Talent Solutions for southeast Asia at Aon, emphasized the dual priorities facing organisations today, "As capital deployment in technology and strategic investments accelerate across southeast Asia, organisations are increasingly focused on retaining top talent and highly skilled employees. Balancing rising compensation costs with the need for agility is key. The most successful firms are leveraging real-time market data and total rewards strategies to stay ahead." Attrition rates for all countries in the region were in double digits. The Philippines and Singapore are projected to have the highest turnover rates at 20.0 percent and 19.3 percent, respectively, followed by Malaysia at 18.2 percent. Attrition rates also vary across industries, with consulting, business and community services highest at 22.6 percent followed by retail at 21.6 percent and manufacturing at 17.5 percent. The study revealed that 42 percent of businesses report challenges in hiring or retaining employees. Additionally, 63 percent are currently facing skills gap challenges, while 12 percent anticipate short-term gaps and 16 percent foresee longer-term gaps. Roles in information technology, engineering and sales remain the hardest to fill, while new hire premiums range between 1.3 to 8.2 percent, lower than the previous year, reflecting higher cost controls. The most in-demand "hot jobs" include sales (24 percent), information technology (24 percent), artificial intelligence (AI)/machine learning (ML) (21 percent), cybersecurity (20 percent) and engineering (19 percent), reflecting a sharp pivot toward digital and risk-focused capabilities. This surge in demand, especially for AI/ML and cybersecurity signals that firms are prioritising sustained compensation strategies to secure future-critical skills in an increasingly competitive market. Evon Lock, head of data solutions for southeast Asia at Aon, said, "Despite the hiring and retention pressures, most organisations remain cautiously optimistic, planning to maintain or modestly grow their workforce. To navigate an uncertain business landscape, firms are prioritising productivity gains, streamlining management layers and adopting targeted hiring strategies and salary increases to engage top performers and build resilient, future-ready teams." More information about Aon in Asia can be found here. Hashtag: #Aon The issuer is solely responsible for the content of this announcement. About AonAon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses. News Source: Aon
08/10/2025 Dissemination of a Financial Press Release, transmitted by EQS News. |
Nachrichten zu Aon PLC Registered Shs
|
05.11.25 |
Increasing Competition, Economic Slowdown and Cyber Threats are Reshaping Asia’s Business Landscape: Aon Survey (EQS Group) | |
|
30.10.25 |
Ausblick: Aon legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
|
16.10.25 |
NYSE-Handel: S&P 500 beginnt Donnerstagssitzung mit Gewinnen (finanzen.ch) | |
|
16.10.25 |
Erste Schätzungen: Aon präsentiert Quartalsergebnisse (finanzen.net) | |
|
15.10.25 |
APAC Employee Medical Plan Costs to Stabilise in 2026 After Two Years of Sharp Increase, Aon reports (EQS Group) | |
|
08.10.25 |
Aon Survey Projects Moderate Salary Growth of 5.3 percent for Southeast Asia in 2026 (EQS Group) | |
|
29.09.25 |
Aon Appoints Shinji Kuriyama as Enterprise Client Leader for Japan (EQS Group) | |
|
03.09.25 |
Aon Study Highlights Strategic Wellbeing Imperatives for Chinese Insurers to Build Capability and Address Medical Inflation Costs (EQS Group) |
Analysen zu Aon PLC Registered Shs
Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Shutdown-Ende in Sicht? US-Börsen mit Gewinnen -- SMI und DAX schlussendlich stärker -- Asiens Börsen letztlich in GrünDer heimische Aktienmarkt präsentierte sich am Montag mit Gewinnen. Anleger am deutschen Aktienmarkt wurden ebenso wieder mutiger. Die Wall Street beginnt die Woche fester. An den Märkten in Fernost ging es zum Wochenstart nach oben.


